VivoSim Labs, Inc.
VIVS
$1.47
$0.053.52%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 32.11% | -49.59% | -72.01% | -83.60% | -70.54% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 32.11% | -49.59% | -72.01% | -83.60% | -70.54% |
| Cost of Revenue | -8.51% | -47.05% | -49.29% | -45.06% | -38.12% |
| Gross Profit | 9.33% | 46.98% | 48.39% | 43.18% | 36.71% |
| SG&A Expenses | -20.28% | -26.47% | -21.55% | -5.07% | 5.22% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -16.03% | -36.63% | -35.04% | -24.99% | -16.05% |
| Operating Income | 16.37% | 36.48% | 34.34% | 23.60% | 14.92% |
| Income Before Tax | 83.05% | 35.11% | 33.10% | 22.61% | 15.00% |
| Income Tax Expenses | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Earnings from Continuing Operations | 83.04% | 35.11% | 33.09% | 22.60% | 15.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 83.04% | 35.11% | 33.09% | 22.60% | 15.00% |
| EBIT | 16.37% | 36.48% | 34.34% | 23.60% | 14.92% |
| EBITDA | 16.59% | 37.02% | 34.68% | 23.85% | 15.09% |
| EPS Basic | 85.18% | 61.27% | 50.73% | 32.43% | 15.75% |
| Normalized Basic EPS | 55.58% | 61.59% | 51.03% | 32.61% | 15.83% |
| EPS Diluted | 85.06% | 61.18% | 50.64% | 32.34% | 15.75% |
| Normalized Diluted EPS | 55.58% | 61.59% | 51.03% | 32.61% | 15.83% |
| Average Basic Shares Outstanding | 91.11% | 45.99% | 58.62% | 77.22% | 154.74% |
| Average Diluted Shares Outstanding | 91.11% | 45.99% | 58.62% | 77.22% | 154.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |